Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-002956
Filing Date
2021-01-22
Accepted
2021-01-22 16:53:07
Documents
2
Period of Report
2021-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4543
2 EX-24 DOCUMENT attachment1.htm EX-24 4588
  Complete submission text file 0000899243-21-002956.txt   10570
Mailing Address 39 BLISS AVENUE TENAFLY NJ 07670
Business Address
Dhingra Kapil (Reporting) CIK: 0001456849 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 21546495

Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)